<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="MEDLINE" Owner="NLM">        <PMID Version="1">30042172</PMID>        <DateCompleted>            <Year>2018</Year>            <Month>09</Month>            <Day>26</Day>        </DateCompleted>        <DateRevised>            <Year>2018</Year>            <Month>10</Month>            <Day>02</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1469-9001</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>24</Volume>                    <Issue>10</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>10</Month>                    </PubDate>                </JournalIssue>                <Title>RNA (New York, N.Y.)</Title>                <ISOAbbreviation>RNA</ISOAbbreviation>            </Journal>            <ArticleTitle>Coregulation of alternative splicing by hnRNPM and ESRP1 during EMT.</ArticleTitle>            <Pagination>                <MedlinePgn>1326-1338</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1261/rna.066712.118</ELocationID>            <Abstract>                <AbstractText>The epithelial-mesenchymal transition (EMT) is a fundamental developmental process that is abnormally activated in cancer metastasis. Dynamic changes in alternative splicing occur during EMT. ESRP1 and hnRNPM are splicing regulators that promote an epithelial splicing program and a mesenchymal splicing program, respectively. The functional relationships between these splicing factors in the genome scale remain elusive. Comparing alternative splicing targets of hnRNPM and ESRP1 revealed that they coregulate a set of cassette exon events, with the majority showing discordant splicing regulation. Discordant splicing events regulated by hnRNPM show a positive correlation with splicing during EMT; however, concordant events do not, indicating the role of hnRNPM in regulating alternative splicing during EMT is more complex than previously understood. Motif enrichment analysis near hnRNPM-ESRP1 coregulated exons identifies guanine-uridine rich motifs downstream from hnRNPM-repressed and ESRP1-enhanced exons, supporting a general model of competitive binding to these <i>cis</i>-elements to antagonize alternative splicing. The set of coregulated exons are enriched in genes associated with cell migration and cytoskeletal reorganization, which are pathways associated with EMT. Splicing levels of coregulated exons are associated with breast cancer patient survival and correlate with gene sets involved in EMT and breast cancer subtyping. This study identifies complex modes of interaction between hnRNPM and ESRP1 in regulation of splicing in disease-relevant contexts.</AbstractText>                <CopyrightInformation>Â© 2018 Harvey et al.; Published by Cold Spring Harbor Laboratory Press for the RNA Society.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Harvey</LastName>                    <ForeName>Samuel E</ForeName>                    <Initials>SE</Initials>                    <AffiliationInfo>                        <Affiliation>Lester and Sue Smith Breast Center, Department of Molecular and Human Genetics, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xu</LastName>                    <ForeName>Yilin</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Lin</LastName>                    <ForeName>Xiaodan</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Lester and Sue Smith Breast Center, Department of Molecular and Human Genetics, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Gao</LastName>                    <ForeName>Xin D</ForeName>                    <Initials>XD</Initials>                    <AffiliationInfo>                        <Affiliation>Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Qiu</LastName>                    <ForeName>Yushan</ForeName>                    <Initials>Y</Initials>                    <AffiliationInfo>                        <Affiliation>Lester and Sue Smith Breast Center, Department of Molecular and Human Genetics, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Ahn</LastName>                    <ForeName>Jaegyoon</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Integrative Biology and Physiology and the Molecular Biology Institute, University of California Los Angeles, Los Angeles, California 90095, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Xiao</LastName>                    <ForeName>Xinshu</ForeName>                    <Initials>X</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Integrative Biology and Physiology and the Molecular Biology Institute, University of California Los Angeles, Los Angeles, California 90095, USA.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Cheng</LastName>                    <ForeName>Chonghui</ForeName>                    <Initials>C</Initials>                    <AffiliationInfo>                        <Affiliation>Lester and Sue Smith Breast Center, Department of Molecular and Human Genetics, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>U01 HG009417</GrantID>                    <Acronym>HG</Acronym>                    <Agency>NHGRI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>R01 GM110146</GrantID>                    <Acronym>GM</Acronym>                    <Agency>NIGMS NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>F30 CA196118</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>R01 HG006264</GrantID>                    <Acronym>HG</Acronym>                    <Agency>NHGRI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>R01 CA182467</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>                <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>07</Month>                <Day>24</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>RNA</MedlineTA>            <NlmUniqueID>9509184</NlmUniqueID>            <ISSNLinking>1355-8382</ISSNLinking>        </MedlineJournalInfo>        <ChemicalList>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="C539364">ESRP1 protein, human</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D034761">Heterogeneous-Nuclear Ribonucleoprotein Group M</NameOfSubstance>            </Chemical>            <Chemical>                <RegistryNumber>0</RegistryNumber>                <NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance>            </Chemical>        </ChemicalList>        <CitationSubset>IM</CitationSubset>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50</RefSource>                <PMID Version="1">16199517</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>RNA Biol. 2008 Jul-Sep;5(3):115-9</RefSource>                <PMID Version="1">19182522</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2014 Dec 23;111(51):E5593-601</RefSource>                <PMID Version="1">25480548</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>PLoS Genet. 2011 Aug;7(8):e1002218</RefSource>                <PMID Version="1">21876675</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2010 May 6;465(7294):53-9</RefSource>                <PMID Version="1">20445623</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogenesis. 2017 Nov 20;6(11):e391</RefSource>                <PMID Version="1">29155418</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>RNA Biol. 2009 Nov-Dec;6(5):546-62</RefSource>                <PMID Version="1">19829082</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Cell Sci. 2016 Apr 1;129(7):1355-65</RefSource>                <PMID Version="1">26869223</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2017 Jul 15;77(14):3791-3801</RefSource>                <PMID Version="1">28533273</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2017 Dec 1;45(21):12270-12284</RefSource>                <PMID Version="1">29036465</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Dev Cell. 2008 Jun;14(6):818-29</RefSource>                <PMID Version="1">18539112</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Wiley Interdiscip Rev RNA. 2015 May-Jun;6(3):311-26</RefSource>                <PMID Version="1">25630614</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Methods. 2001 Dec;25(4):402-8</RefSource>                <PMID Version="1">11846609</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2009 Nov 25;139(5):871-90</RefSource>                <PMID Version="1">19945376</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2014 Sep 4;33(36):4485-95</RefSource>                <PMID Version="1">24077287</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>EMBO Rep. 2010 Jun;11(6):445-51</RefSource>                <PMID Version="1">20467437</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 2013 Jan;33(2):396-405</RefSource>                <PMID Version="1">23149937</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2016 Apr 21;165(3):606-19</RefSource>                <PMID Version="1">27104978</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Elife. 2015 Sep 15;4:null</RefSource>                <PMID Version="1">26371508</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Bioinformatics. 2013 Jan 1;29(1):15-21</RefSource>                <PMID Version="1">23104886</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2010 Aug 31;107(35):15449-54</RefSource>                <PMID Version="1">20713713</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2009 Jan;37(1):1-13</RefSource>                <PMID Version="1">19033363</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>EMBO J. 2010 Oct 6;29(19):3286-300</RefSource>                <PMID Version="1">20711167</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Cell. 2003 Jun;3(6):537-49</RefSource>                <PMID Version="1">12842083</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 2012 Apr;32(8):1468-82</RefSource>                <PMID Version="1">22354987</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Dev. 2008 Apr 1;22(7):894-907</RefSource>                <PMID Version="1">18381893</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Sep 6;489(7414):57-74</RefSource>                <PMID Version="1">22955616</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Mammary Gland Biol Neoplasia. 2010 Jun;15(2):235-52</RefSource>                <PMID Version="1">20521089</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Commun. 2012 Jun 06;3:883</RefSource>                <PMID Version="1">22673910</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Oncogene. 2014 Feb 27;33(9):1082-92</RefSource>                <PMID Version="1">23435423</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Genet. 2003 Jul;34(3):267-73</RefSource>                <PMID Version="1">12808457</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Invest. 2011 Mar;121(3):1064-74</RefSource>                <PMID Version="1">21393860</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell. 2016 Jun 30;166(1):21-45</RefSource>                <PMID Version="1">27368099</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genome Res. 2012 Sep;22(9):1760-74</RefSource>                <PMID Version="1">22955987</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Res. 2003 May 1;63(9):2172-8</RefSource>                <PMID Version="1">12727836</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Immunol Res. 2016 Jun;4(6):552-61</RefSource>                <PMID Version="1">27045022</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nucleic Acids Res. 2010 Apr;38(6):1964-81</RefSource>                <PMID Version="1">20044351</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell. 2009 Mar 13;33(5):591-601</RefSource>                <PMID Version="1">19285943</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>EMBO J. 2015 Mar 4;34(5):653-68</RefSource>                <PMID Version="1">25599992</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2008 Nov 27;456(7221):470-6</RefSource>                <PMID Version="1">18978772</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Wiley Interdiscip Rev RNA. 2013 Sep-Oct;4(5):547-66</RefSource>                <PMID Version="1">23765697</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Dev Cell. 2013 Dec 9;27(5):560-73</RefSource>                <PMID Version="1">24331928</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Rep. 2014 Mar 27;6(6):1139-1152</RefSource>                <PMID Version="1">24613350</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Elife. 2014 Jun 04;3:null</RefSource>                <PMID Version="1">24898756</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2012 Oct 4;490(7418):61-70</RefSource>                <PMID Version="1">23000897</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Chromosomes Cancer. 2017 Aug;56(8):598-607</RefSource>                <PMID Version="1">28393427</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Med Oncol. 2015 May;32(5):159</RefSource>                <PMID Version="1">25850653</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Dev. 2014 Jun 1;28(11):1191-203</RefSource>                <PMID Version="1">24840202</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2010;12(5):R68</RefSource>                <PMID Version="1">20813035</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nature. 2005 Jul 28;436(7050):518-24</RefSource>                <PMID Version="1">16049480</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Biol Chem. 2012 Oct 19;287(43):36435-42</RefSource>                <PMID Version="1">22961986</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Protoc. 2009;4(1):44-57</RefSource>                <PMID Version="1">19131956</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Genes Dev. 2014 Mar 15;28(6):637-51</RefSource>                <PMID Version="1">24637117</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Methods Mol Biol. 2016;1402:229-241</RefSource>                <PMID Version="1">26721495</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Nat Genet. 2008 Dec;40(12):1413-5</RefSource>                <PMID Version="1">18978789</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Curr Opin Cell Biol. 2003 Dec;15(6):740-6</RefSource>                <PMID Version="1">14644200</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):8366-8371</RefSource>                <PMID Version="1">28716909</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cancer Res. 2015 Feb;13(2):305-18</RefSource>                <PMID Version="1">25274489</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cell Rep. 2012 Feb 23;1(2):167-78</RefSource>                <PMID Version="1">22574288</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Mol Cell Biol. 2016 May 16;36(11):1704-19</RefSource>                <PMID Version="1">27044866</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <MeshHeadingList>            <MeshHeading>                <DescriptorName UI="D017398" MajorTopicYN="Y">Alternative Splicing</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001665" MajorTopicYN="N">Binding Sites</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D058750" MajorTopicYN="N">Epithelial-Mesenchymal Transition</DescriptorName>                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005091" MajorTopicYN="N">Exons</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D005786" MajorTopicYN="Y">Gene Expression Regulation</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015972" MajorTopicYN="N">Gene Expression Regulation, Neoplastic</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D034761" MajorTopicYN="N">Heterogeneous-Nuclear Ribonucleoprotein Group M</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D059372" MajorTopicYN="N">Nucleotide Motifs</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName>                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>            </MeshHeading>            <MeshHeading>                <DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName>            </MeshHeading>        </MeshHeadingList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="Y">EMT</Keyword>            <Keyword MajorTopicYN="Y">ESRP1</Keyword>            <Keyword MajorTopicYN="Y">RNA binding proteins</Keyword>            <Keyword MajorTopicYN="Y">alternative splicing</Keyword>            <Keyword MajorTopicYN="Y">hnRNPM</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>04</Month>                <Day>10</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>07</Month>                <Day>18</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pmc-release">                <Year>2019</Year>                <Month>10</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>7</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>27</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>7</Month>                <Day>26</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30042172</ArticleId>            <ArticleId IdType="pii">rna.066712.118</ArticleId>            <ArticleId IdType="doi">10.1261/rna.066712.118</ArticleId>            <ArticleId IdType="pmc">PMC6140460</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>